The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Seed | Alive

Total Raised


Last Raised

$20K | 7 yrs ago

About EditBIOMED

EditBIOMED specializes in editing biomedical manuscripts, grants, and other scientific documents for non-native English-speaking scientists.

EditBIOMED Headquarter Location

Hoover, Alabama,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing EditBIOMED

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

EditBIOMED is included in 1 Expert Collection, including Digital Health.


Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

  • Where is EditBIOMED's headquarters?

    EditBIOMED's headquarters is located at Hoover.

  • What is EditBIOMED's latest funding round?

    EditBIOMED's latest funding round is Seed.

  • How much did EditBIOMED raise?

    EditBIOMED raised a total of $20K.

  • Who are the investors of EditBIOMED?

    Investors of EditBIOMED include Alabama Launchpad.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.